CDP PROTEIN SECRETION INHIBITORS
Provided herein are compounds that inhibit protein secretion, e.g., via inhibition of Sec61. Also provided are compositions of the inhibitor compounds, and methods of using these inhibitors. The compounds disclosed herein can be used, e.g., for the treatment of cancer, arthritis, and/or inflammation...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Taunton, John William Sharp, Phillip Patrick McMinn, Dustin |
description | Provided herein are compounds that inhibit protein secretion, e.g., via inhibition of Sec61. Also provided are compositions of the inhibitor compounds, and methods of using these inhibitors. The compounds disclosed herein can be used, e.g., for the treatment of cancer, arthritis, and/or inflammation. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2021017233A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2021017233A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2021017233A13</originalsourceid><addsrcrecordid>eNrjZFBwdglQCAjyD3H19FMIdnUOcg3x9PdT8PTz8HTyDPEPCuZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGRoYGhuZGxsaOhsbEqQIAh7ci5A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CDP PROTEIN SECRETION INHIBITORS</title><source>esp@cenet</source><creator>Taunton, John William ; Sharp, Phillip Patrick ; McMinn, Dustin</creator><creatorcontrib>Taunton, John William ; Sharp, Phillip Patrick ; McMinn, Dustin</creatorcontrib><description>Provided herein are compounds that inhibit protein secretion, e.g., via inhibition of Sec61. Also provided are compositions of the inhibitor compounds, and methods of using these inhibitors. The compounds disclosed herein can be used, e.g., for the treatment of cancer, arthritis, and/or inflammation.</description><language>eng</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210121&DB=EPODOC&CC=US&NR=2021017233A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210121&DB=EPODOC&CC=US&NR=2021017233A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Taunton, John William</creatorcontrib><creatorcontrib>Sharp, Phillip Patrick</creatorcontrib><creatorcontrib>McMinn, Dustin</creatorcontrib><title>CDP PROTEIN SECRETION INHIBITORS</title><description>Provided herein are compounds that inhibit protein secretion, e.g., via inhibition of Sec61. Also provided are compositions of the inhibitor compounds, and methods of using these inhibitors. The compounds disclosed herein can be used, e.g., for the treatment of cancer, arthritis, and/or inflammation.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFBwdglQCAjyD3H19FMIdnUOcg3x9PdT8PTz8HTyDPEPCuZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGRoYGhuZGxsaOhsbEqQIAh7ci5A</recordid><startdate>20210121</startdate><enddate>20210121</enddate><creator>Taunton, John William</creator><creator>Sharp, Phillip Patrick</creator><creator>McMinn, Dustin</creator><scope>EVB</scope></search><sort><creationdate>20210121</creationdate><title>CDP PROTEIN SECRETION INHIBITORS</title><author>Taunton, John William ; Sharp, Phillip Patrick ; McMinn, Dustin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2021017233A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>Taunton, John William</creatorcontrib><creatorcontrib>Sharp, Phillip Patrick</creatorcontrib><creatorcontrib>McMinn, Dustin</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Taunton, John William</au><au>Sharp, Phillip Patrick</au><au>McMinn, Dustin</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CDP PROTEIN SECRETION INHIBITORS</title><date>2021-01-21</date><risdate>2021</risdate><abstract>Provided herein are compounds that inhibit protein secretion, e.g., via inhibition of Sec61. Also provided are compositions of the inhibitor compounds, and methods of using these inhibitors. The compounds disclosed herein can be used, e.g., for the treatment of cancer, arthritis, and/or inflammation.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US2021017233A1 |
source | esp@cenet |
subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
title | CDP PROTEIN SECRETION INHIBITORS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T12%3A40%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Taunton,%20John%20William&rft.date=2021-01-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2021017233A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |